Inferra AI / Company / HSIC

Henry Schein

HSIC · Health Care

Last earnings Aug 4, 2026

Key results

GAAP EPSquarter

$0.70

GAAP diluted EPS of $0.70, compared to $0.80 GAAP diluted EPS in the second quarter of 2024 Second-quarter 2025 non-GAAP

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Global Technology revenuequarter

7.4%

Global Technology sales for the quarter increased 7.4%, and by 6.6% in constant currencies compared with the second quarter of 2024, reflecting strong sales growth in practice management systems, including Dentrix Ascend and Dentally cloud-based solutions, as well as in revenue cycle management products.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

GAAP net incomequarter

$86 million

GAAP net income 2 for the quarter was $86 million, or $0.70 per diluted share 4 , and compares with second-quarter 2024 GAAP net income of $104 million, or $0.80 per diluted share.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Non-GAAP net incomequarter

$135 million

Non-GAAP net income 2 for the quarter was $135 million, or $1.10 per diluted share 4 , and compares with second- quarter 2024 non-GAAP net income of $158 million, or $1.23 per diluted share.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Net incomequarter

$158 million

Non-GAAP net income 2 for the quarter was $135 million, or $1.10 per diluted share 4 , and compares with second- quarter 2024 non-GAAP net income of $158 million, or $1.23 per diluted share.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

GAAP net income 2 for the first half of the year was $196 million, or $1.58 per diluted share 4 , and compares with first half of 2024 GAAP net income of $197 million, or $1.52 per diluted share.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

-3- more Non-GAAP net income 2 for the first half of the year was $278 million, or $2.25 per diluted share 4 , and compares with first half 2024 non-GAAP net income of $301 million, or $2.33 per diluted share.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

AI analysis

Q2 2025 · reported Aug 5, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

GAAP EPS · Q2 2025
$0.70
-12.5% vs year ago computed from stated figures
EX-99 · Aug 5, 2025
GAAP net income · Q2 2025
$86M
EX-99 · Aug 5, 2025
Diluted EPS · non-GAAP · Q2 2025
$1.10
EX-99 · Aug 5, 2025
Non-GAAP net income · Q2 2025
$135M
EX-99 · Aug 5, 2025

The quarter in charts

Diluted EPS — GAAP

Per diluted share, as stated

00.30.60.9$0.80Same quarter last year$0.70Q2 2025 (quarter)

EX-99 · Aug 5, 2025 EPS values as stated in the release.

Headline figures

MetricQ2 2025Prior qtrYear ago
GAAP EPS$0.70—$0.80
Global Technology revenue7.4%——
GAAP net income$86 million——
Non-GAAP net income$135 million——
Net income$158 million——

EX-99 · Aug 5, 2025

Guidance · company-stated

Direction: Reiterated

Revenue

“htm PRESS RELEASE AUGUST 5, 2025 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS Second-quarter 2025 GAAP diluted EPS of $0.70, compared to $0.80 GAAP diluted EPS in the second quarter of 2024 Second-quarter 2025 non-GAAP diluted EPS of $1.10, compared to $1.23 non-GAAP diluted EPS in the second quarter of 2024 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted EBITDA growth, and sales growth of 2% to 4% Takes next steps in collaboration with KKR to pursue additional opportunities to create shareholder value MELVILLE, N.”

Company outlook — Reiterated

“Our full-year guidance, which we are maintaining, continues to reflect earnings weighted to the second half of the year.”

Company outlook — Reiterated

“2025 Financial Guidance Henry Schein today maintained its financial guidance for 2025.”

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Share Repurchases During the second quarter of 2025, the Company repurchased approximately 3.7 million shares of common stock at an average price of $70.88 per share for a total of $259 million.

This included approximately 3.1 million shares of its common stock under its previously announced Accelerated Stock Repurchase plan (ASR) at an average price of $71.60 per share, for a total of $223 million, which followed the Company s sale of 3.3 million shares of common stock at an average price of $76.10 per share for a total of $250 million, to KKR.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

We are pleased with the results from these initiatives and have returned to normal levels of promotional activity

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Direction: Reiterated

Revenue: “htm PRESS RELEASE AUGUST 5, 2025 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS Second-quarter 2025 GAAP diluted EPS of $0.70, compared to $0.80 GAAP diluted EPS in the second quarter of 2024 Second-quarter 2025 non-GAAP diluted EPS of $1.10, compared to $1.23 non-GAAP diluted EPS in the second quarter of 2024 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted EBITDA growth, and sales growth of 2% to 4% Takes next steps in collaboration with KKR to pursue additional opportunities to create shareholder value MELVILLE, N.”

Revenue — Reiterated (“Maintains”)
“htm PRESS RELEASE AUGUST 5, 2025 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS Second-quarter 2025 GAAP diluted EPS of $0.70, compared to $0.80 GAAP diluted EPS in the second quarter of 2024 Second-quarter 2025 non-GAAP diluted EPS of $1.10, compared to $1.23 non-GAAP diluted EPS in the second quarter of 2024 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted EBITDA growth, and sales growth of 2% to 4% Takes next steps in collaboration with KKR to pursue additional opportunities to create shareholder value MELVILLE, N.”

Company outlook — Reiterated (“maintaining”)
“Our full-year guidance, which we are maintaining, continues to reflect earnings weighted to the second half of the year.”

Company outlook — Reiterated (“maintained”)
“2025 Financial Guidance Henry Schein today maintained its financial guidance for 2025.”

Classified from the release's primary full-year outlook statement.

Capital allocation

Share Repurchases During the second quarter of 2025, the Company repurchased approximately 3.7 million shares of common stock at an average price of $70.88 per share for a total of $259 million.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

This included approximately 3.1 million shares of its common stock under its previously announced Accelerated Stock Repurchase plan (ASR) at an average price of $71.60 per share, for a total of $223 million, which followed the Company s sale of 3.3 million shares of common stock at an average price of $76.10 per share for a total of $250 million, to KKR.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

In addition, the Company repurchased approximately 0.5 million shares of common stock at an average price of $67.36 per share, for a total of $36 million.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

The impact of these share repurchases on second-quarter diluted EPS was immaterial.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

At the end of the quarter, Henry Schein had $432 million authorized and available for future stock repurchases, plus a further $27 million authorized under the ASR.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

At June 27, 2026 and December 27, 2025, amounts include trade accounts receivable of $ 526 million and $ 491 million, respectively, and long-term debt of $ 430 million and $ 390 million, respectively.

SEC original ↗Henry Schein — 10-Q Quarterly report10-QAug 4, 2026

Strategy & priorities

versus the prior year primarily resulting from lower glove pricing as well as time-limited targeted sales initiatives.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

We are pleased with the results from these initiatives and have returned to normal levels of promotional activity.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Partnering with KKR Capstone, we have engaged two leading global management consulting firms to support our efforts to enhance distribution gross margins, including accelerating sales of our owned-products portfolio, and to support our ongoing company-wide initiatives to increase efficiencies.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

We expect these projects, which expand on our BOLD+1 strategy, to start producing results towards the beginning of 2026, and will support our ongoing initiatives to drive superior customer satisfaction and our financial goal of high-single digit to low-double digit earnings growth, Mr.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

volume increased at lower average selling prices compared with the second quarter of 2024, partly due to glove pricing and time-limited targeted sales initiatives.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Risks & headwinds

, resulting from a slow-down in orders beginning in May due to short-term economic uncertainty resulting from tariffs, which then returned to normal by the end of the quarter.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Guidance is for current continuing operations as well as acquisitions that have closed and does not include the impact of restructuring expenses, amortization expense of acquired intangible assets, the insurance claim recovery associated with the cybersecurity incident, changes in contingent consideration, costs associated with shareholder advisory matters and select value creation consulting costs, and litigation settlements.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

This guidance also assumes that foreign currency exchange rates will remain generally consistent with current levels, that the effects of tariffs can be mitigated, and includes expected remeasurement gains related to the purchase of controlling interests of previously held non-controlling equity investments, consistent with business strategy.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

The inability to provide this reconciliation is due to the uncertainty and inherent difficulty of predicting the occurrence, magnitude, financial impact and timing of related costs.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

SEC original ↗Henry Schein — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Documents

Filings

25 documents

Earnings releases

9 documents

Presentations

0 documents

No presentations for Henry Schein are held in this edition of the library.

Transcripts

0 documents

No transcripts for Henry Schein are held in this edition of the library.

Mentioned by

1 company

Other tracked companies whose held documents mention Henry Schein by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.